Royal Bank of Canada
VERA icon

Royal Bank of Canada’s Vera Therapeutics VERA Stock Holding History

Royal Bank of Canada’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$804K Buy
19,987
+13,108
+191% +$565K ﹤0.01% 3792
2025
Q4 		$348K Sell
6,879
-19,692
-74% -$699K ﹤0.01% 4428
2025
Q3 		$773K Buy
26,571
+7,183
+37% +$166K ﹤0.01% 4178
2025
Q2 		$458K Buy
19,388
+18,338
+1,746% +$412K ﹤0.01% 4539
2025
Q1 		$25K Sell
1,050
-1,206
-53% -$38.8K ﹤0.01% 5844
2024
Q4 		$95K Sell
2,256
-3,065
-58% -$136K ﹤0.01% 5368
2024
Q3 		$235K Buy
5,321
+738
+16% +$28K ﹤0.01% 4693
2024
Q2 		$166K Sell
4,583
-2,267
-33% -$89.9K ﹤0.01% 4905
2024
Q1 		$297K Sell
6,850
-3,940
-37% -$140K ﹤0.01% 4365
2023
Q4 		$166K Buy
10,790
+5,199
+93% +$66K ﹤0.01% 5258
2023
Q3 		$77K Buy
5,591
+2,252
+67% +$38.6K ﹤0.01% 5549
2023
Q2 		$54K Buy
3,339
+1,625
+95% +$14.7K ﹤0.01% 5747
2023
Q1 		$13K Sell
1,714
-819
-32% -$6.32K ﹤0.01% 6212
2022
Q4 		$49K Buy
2,533
+1,862
+277% +$33.7K ﹤0.01% 5894
2022
Q3 		$15K Buy
671
+93
+16% +$1.74K ﹤0.01% 6265
2022
Q2 		$8K Sell
578
-763
-57% -$13.3K ﹤0.01% 6485
2022
Q1 		$32K Sell
1,341
-1,355
-50% -$29.2K ﹤0.01% 6355
2021
Q4 		$72K Buy
2,696
+1,916
+246% +$42.4K ﹤0.01% 6163
2021
Q3 		$13K Buy
+780
New +$13.9K ﹤0.01% 6881

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada's VERA Position: Q1 2026 in Review

Royal Bank of Canada increased its Vera Therapeutics (VERA) stake by 191% in Q1 2026, buying an estimated $565K and bringing the position to 19,987 shares worth $804K. The position accounts for ﹤0.01% of the portfolio, ranked #3792.

Royal Bank of Canada first reported a position in VERA in Q3 2021 and has held it in 19 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Royal Bank of Canada held 19,987 shares of Vera Therapeutics worth $804K as of Q1 2026.
  • Royal Bank of Canada bought 13,108 Vera Therapeutics shares in Q1 2026, an estimated $565K.
  • Vera Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3792 holding.
  • Royal Bank of Canada first reported a position in Vera Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.